Arkolith/Insider Trading/RAPP/Form 4

Ceesay Abraham

Chief Executive Officer, DirectorRapport Therapeutics, Inc. (RAPP) · full profile →Form 4 · filed Sep 19, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 17, 2025Sell(S)39K$26.30$1.0M587K
Sep 17, 2025Sell(S)1K$26.87$38K585K
Sep 17, 2025Sell(S)35K$26.30$917K47K
Sep 17, 2025Sell(S)700$27.04$19K46K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-209062) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML